Role of Radioembolization in Metastatic Neuroendocrine Tumors.
Cardiovasc Intervent Radiol
; 45(11): 1590-1598, 2022 Nov.
Article
en En
| MEDLINE
| ID: mdl-35918431
ABSTRACT
The liver is the most common site of metastasis for neuroendocrine tumors originating from the gastrointestinal tract. Neuroendocrine liver metastases (NELMs) portend a worsening clinical course, making local management important. Local treatment options include surgery, thermal ablation, and trans-catheter intra-arterial therapies, such as radioembolization. Radioembolization is generally preferred over other embolotherapies in patients with colonized biliary systems. Current best practice involves personalized treatment planning, optimizing tumor radiation absorbed dose and minimizing radiation to the normal hepatic parenchyma. As part of a multidisciplinary approach, radioembolization is a versatile embolotherapy offering neoadjuvant, palliative, and ablative treatment options for patients with NELMs.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Braquiterapia
/
Tumores Neuroendocrinos
/
Embolización Terapéutica
/
Neoplasias Hepáticas
Tipo de estudio:
Guideline
Límite:
Humans
Idioma:
En
Revista:
Cardiovasc Intervent Radiol
Año:
2022
Tipo del documento:
Article
País de afiliación:
Estados Unidos